Item Type | Name |
Concept
|
Bacterial Infections
|
Concept
|
Bordetella Infections
|
Concept
|
Clostridium Infections
|
Concept
|
Cross Infection
|
Concept
|
Cytomegalovirus Infections
|
Concept
|
Opportunistic Infections
|
Concept
|
Pneumococcal Infections
|
Concept
|
Respiratory Tract Infections
|
Concept
|
Mycobacterium Infections, Nontuberculous
|
Concept
|
Respiratory Syncytial Virus Infections
|
Concept
|
HIV Infections
|
Concept
|
AIDS-Related Opportunistic Infections
|
Concept
|
Coronavirus Infections
|
Academic Article
|
Working memory deficits in HIV-seropositive drug users.
|
Academic Article
|
Delayed recognition memory span in HIV-1 infection.
|
Academic Article
|
Information processing and antiretroviral therapy in HIV-1 infection.
|
Academic Article
|
Impaired phagocyte oxidative capacity in patients with human immunodeficiency virus infection.
|
Academic Article
|
Posaconazole salvage therapy allows successful allogeneic hematopoietic stem cell transplantation in patients with refractory invasive mold infections.
|
Academic Article
|
Clinical outcomes, safety, and pharmacokinetics of OPT-80 in a phase 2 trial with patients with Clostridium difficile infection.
|
Academic Article
|
Fidaxomicin: first-in-class macrocyclic antibiotic.
|
Academic Article
|
Fidaxomicin versus vancomycin for Clostridium difficile infection.
|
Academic Article
|
Reduced acquisition and overgrowth of vancomycin-resistant enterococci and Candida species in patients treated with fidaxomicin versus vancomycin for Clostridium difficile infection.
|
Academic Article
|
Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections.
|
Academic Article
|
Reaction times are faster in HIV-seropositive patients on antiretroviral therapy: A preliminary report.
|
Academic Article
|
Renal impairment and clinical outcomes of Clostridium difficile infection in two randomized trials.
|
Academic Article
|
Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy.
|
Academic Article
|
Emerging therapies for Clostridium difficile infection - focus on fidaxomicin.
|
Academic Article
|
Pharmacokinetics of LFF571 and vancomycin in patients with moderate Clostridium difficile infections.
|
Academic Article
|
Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adults.
|
Academic Article
|
Multicenter, randomized clinical trial to compare the safety and efficacy of LFF571 and vancomycin for Clostridium difficile infections.
|
Academic Article
|
CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation.
|
Academic Article
|
Fidaxomicin in Clostridium difficile infection: latest evidence and clinical guidance.
|
Academic Article
|
Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation.
|
Academic Article
|
Safety and Durability of RBX2660 (Microbiota Suspension) for Recurrent Clostridium difficile Infection: Results of the PUNCH CD Study.
|
Academic Article
|
Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates.
|
Academic Article
|
Surotomycin versus vancomycin for Clostridium difficile infection: Phase 2, randomized, controlled, double-blind, non-inferiority, multicentre trial.
|
Academic Article
|
Brincidofovir treatment of acyclovir-resistant disseminated varicella zoster virus infection in an immunocompromised host.
|
Academic Article
|
Clearance of Vancomycin-Resistant Enterococcus Concomitant With Administration of a Microbiota-Based Drug Targeted at Recurrent Clostridium difficile Infection.
|
Academic Article
|
Primary Outcomes From a Phase 3, Randomized, Double-Blind, Active-Controlled Trial of Surotomycin in Subjects With Clostridium difficile Infection.
|
Academic Article
|
Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species.
|
Academic Article
|
Isavuconazole for treatment of rare invasive fungal diseases.
|
Academic Article
|
Misdiagnosis of Bordetella bronchiseptica Respiratory Infection as Bordetella pertussis by Multiplex Molecular Assay.
|
Academic Article
|
Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease.
|
Academic Article
|
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation.
|
Academic Article
|
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation.
|
Academic Article
|
The Impact of Recurrent Clostridium difficile Infection on Patients' Prevention Behaviors.
|
Academic Article
|
Clinical and magnetic resonance imaging regression of progressive multifocal leukoencephalopathy in an AIDS patient after intensive antiretroviral therapy.
|
Academic Article
|
Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial.
|
Academic Article
|
Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials.
|
Academic Article
|
Management of Clostridioides (formerly Clostridium) difficile infection (CDI) in solid organ transplant recipients: Guidelines from the American Society of Transplantation Community of Practice.
|
Academic Article
|
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients.
|
Academic Article
|
A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory Tract.
|
Academic Article
|
Exploratory Evaluation of Bezlotoxumab on Outcomes Associated With Clostridioides difficile Infection in MODIFY I/II Participants With Cancer.
|
Academic Article
|
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.
|
Academic Article
|
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.
|
Academic Article
|
Changes in Intravenous Immunoglobulin Usage for Hypogammaglobulinemia After Implementation of a Stewardship Program.
|
Academic Article
|
Needles in a haystack: Extremely rare invasive fungal infections reported in FungiScope?-Global Registry for Emerging Fungal Infections.
|
Academic Article
|
Cording in Disseminated Mycobacterium chelonae Infection in an Immunocompromised Patient.
|
Academic Article
|
Remdesivir Versus Standard-of-Care for Severe Coronavirus Disease 2019 Infection: An Analysis of 28-Day Mortality.
|
Academic Article
|
American Society for Transplantation and Cellular Therapy Series: #5-Management of Clostridioides difficile Infection in Hematopoietic Cell Transplant Recipients.
|
Concept
|
Invasive Fungal Infections
|
Academic Article
|
A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Allogeneic Hematopoietic Cell Transplant Recipients (PNEU-STEM).
|
Academic Article
|
Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant.
|